EDITAS MEDICINE, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
EDITAS MEDICINE, INC. (EDIT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$656.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-15
- EDITAS MEDICINE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$656.00K.
- EDITAS MEDICINE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$656.00K.
- EDITAS MEDICINE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$713.00K.
- EDITAS MEDICINE, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$1.16M.
- EDITAS MEDICINE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$5.09M.
- EDITAS MEDICINE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.43M.
- EDITAS MEDICINE, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$1.22M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$656.00K 10-Q · filed 2017-05-15 | -$1.31M derived: sum of 2 quarters · filed 2017-05-15 | -$2.02M derived: sum of 3 quarters · filed 2017-05-15 | -$3.19M derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-12-31 | -$656.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$1.37M derived: sum of 2 quarters · filed 2017-03-03 | -$2.53M derived: sum of 3 quarters · filed 2017-03-03 | -$5.09M 10-K · filed 2017-03-03 |
| 2016-09-30 | -$713.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$1.87M derived: sum of 2 quarters · filed 2016-11-09 | -$4.44M 10-Q · filed 2016-11-09 | -$4.84M derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$3.72M 10-Q · filed 2016-08-10 | -$4.12M derived: sum of 3 quarters · filed 2017-05-15 | -$4.31M derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-03-31 | -$2.56M 10-Q · filed 2017-05-15 | -$2.96M derived: sum of 2 quarters · filed 2017-05-15 | -$3.15M derived: sum of 3 quarters · filed 2017-05-15 | -$3.69M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$591.00K derived: sum of 2 quarters · filed 2017-03-03 | -$1.13M derived: sum of 3 quarters · filed 2017-03-03 | -$1.43M 10-K · filed 2017-03-03 |
| 2015-09-30 | -$190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$725.00K derived: sum of 2 quarters · filed 2016-11-09 | -$1.03M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$535.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$840.00K 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$305.00K 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | -$1.22M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |